García-Piñeres A J, Lindenmeyer M T, Merfort I
Department of Pharmaceutical Biology, Institute of Pharmaceutical Science, Albert-Ludwigs-University Freiburg, Stefan-Meier-Str. 19, 79104 Freiburg, Germany.
Life Sci. 2004 Jul 2;75(7):841-56. doi: 10.1016/j.lfs.2004.01.024.
Sesquiterpene lactones (SLs) are potent anti-inflammatory substances. It was previously shown that the anti-inflammatory effect could be partly explained by the inhibition of the transcription factor NF-kappaB. Whether they inhibit the DNA binding of NF-kappaB, the activation of the IkappaB-kinase, or both is still a matter of debate. The data supporting these hypotheses were obtained using different cell systems. In this contribution we analyzed the mechanism of the sesquiterpene lactone-mediated inhibition using different cell systems, and showed that in all the cell lines analyzed, SLs inhibited both NF-kappaB binding and the IkappaB-kinase, but that the former played a more preponderant role in the inhibition. These results again confirm the importance of cysteine 38 in the inhibition and regulation of NF-kappaB's function. Moreover, we compared the selectivity of the SL parthenolide with that of N-ethyl maleimide (NEM). We showed that NEM directly alkylated p65 as well as p50 of NF-kappaB, whereas SLs possess a selectivity towards p65. Finally, we studied the transactivating properties of various p65 mutants, to analyze the effect of exchanged cysteine residues in the DNA binding domain of NF-kappaB/p65 on its function and demonstrated that the transactivating potential of the mutants did not correlate with their DNA binding strenght.
倍半萜内酯(SLs)是强效抗炎物质。先前的研究表明,其抗炎作用部分可通过抑制转录因子NF-κB来解释。它们是抑制NF-κB与DNA的结合、IκB激酶的激活,还是两者都抑制,仍是一个有争议的问题。支持这些假设的数据是使用不同的细胞系统获得的。在本论文中,我们使用不同的细胞系统分析了倍半萜内酯介导的抑制机制,并表明在所分析的所有细胞系中,SLs同时抑制NF-κB结合和IκB激酶,但前者在抑制中起更主要的作用。这些结果再次证实了半胱氨酸38在抑制和调节NF-κB功能中的重要性。此外,我们比较了SL小白菊内酯与N-乙基马来酰亚胺(NEM)的选择性。我们发现NEM直接使NF-κB的p65和p50烷基化,而SLs对p65具有选择性。最后,我们研究了各种p65突变体的反式激活特性,以分析NF-κB/p65的DNA结合结构域中交换的半胱氨酸残基对其功能的影响,并证明突变体的反式激活潜力与其DNA结合强度无关。